Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00474799 · ClinicalTrials.gov registry record · Phase 1

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)

A Phase 1 study of Healthy, sponsored by Javelin Pharmaceuticals.

Completed
Registry status
Phase 1
Development phase
32
Enrollment target
1
Study location

NCT00474799 is a Phase 1 study of Healthy that has completed, run by Javelin Pharmaceuticals. The registered enrollment target is 32 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00474799, a Phase 1 study of Healthy, has completed, sponsored by Javelin Pharmaceuticals.

COMPLETED
Registry status
Phase 1
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to characterize the repeat dosing plasma profile, extent of accumulation and repeat dose pharmacokinetics of morphine, morphine-3-glucuronide, and morphine-6-glucuronide during administration of MNS075 in two different, clinically-relevant dosing schedules.

Conditions Studied

Healthy

Interventions

  • DRUG MNS075

Study Locations (1)

Texas

  • CEDRA Corporation - Austin

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2007-01
Est. Completion 2007-02
Phase Phase 1

Sponsor

Javelin Pharmaceuticals

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00474799

The ClinicalTrials.gov registry entry for NCT00474799 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The listed sponsor is Javelin Pharmaceuticals, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which MNS075 is the first listed.

NCT00474799 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00474799 about?

NCT00474799 is a clinical study titled "Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)". The purpose of this study is to characterize the repeat dosing plasma profile, extent of accumulation and repeat dose pharmacokinetics of morphine, morphine-3-glucuronide, and morphine-6-glucuronide during administration of MNS075 in two different, clinically-relevant dosing schedules.

What is the current status of trial NCT00474799?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2007-01. Estimated completion is 2007-02.

What conditions does trial NCT00474799 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00474799?

The interventions under investigation include: MNS075 (DRUG).

Who is sponsoring clinical trial NCT00474799?

This trial is sponsored by Javelin Pharmaceuticals, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00474799 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.